DXCM logo

DXCM
Dexcom Inc

10,046
Mkt Cap
$26.74B
Volume
10.97M
52W High
$93.25
52W Low
$57.52
PE Ratio
47.75
DXCM Fundamentals
Price
$58.00
Prev Close
$68.20
Open
$59.35
50D MA
$71.52
Beta
0.86
Avg. Volume
6.35M
EPS (Annual)
$1.42
P/B
10.40
Rev/Employee
$391,553.40
Loading...
Loading...
News
all
press releases
Futures Rebound Lifted By Strong Amazon, Apple Earnings
Futures Rebound Lifted By Strong Amazon, Apple Earnings US equity futures rebound from the Thursday drop, led by Mag 7. As of 8:00am ET, S&P futures are 0.8% higher and Nasdaq futures gain 1.2%, on...
Zero Hedge·3h ago
News Placeholder
More News
News Placeholder
Stock Market Today: Traders Seek Turnaround Trade to Cap off Hallow-Week
This live blog is refreshed periodically throughout the day with the latest updates from the market.To find the latest Stock Market Today threads, click here.Happy Friday. This is TheStreet's Stock...
TheStreet.com·4h ago
News Placeholder
Dexcom Stock Plunges 13% After-Hours As Q3 Margin Pressures Eclipse Record Profit — Retail Sees ‘Buy The Dip’ Setup
Stocktwits·14h ago
News Placeholder
DexCom (DXCM) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for DexCom (DXCM) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks·19h ago
News Placeholder
DexCom (DXCM) Surpasses Q3 Earnings and Revenue Estimates
DexCom (DXCM) delivered earnings and revenue surprises of +7.02% and +2.72%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·19h ago
News Placeholder
Dexcom Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Guidance
DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended September 30, 2025. Third Quarter 2025 Financial Highlights: Revenue grew 22% year-over-year to $1.209...
Business Wire·20h ago
News Placeholder
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DexCom, Inc. (DexCom or the Company) (NASDAQ: DXCM) for violations of 10(b) and...
Business Wire·2d ago
News Placeholder
Insights Into DexCom (DXCM) Q3: Wall Street Projections for Key Metrics
Beyond analysts' top-and-bottom-line estimates for DexCom (DXCM), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2025.
Zacks·2d ago
News Placeholder
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit PR Newswire NEW YORK, Oct. 28, 2025 NEW...
PR Newswire·3d ago
News Placeholder
DCXM ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of DexCom, Inc. Investors
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired DexCom, Inc. (DexCom or the Company) (NASDAQ:DXCM) securities during the...
Business Wire·3d ago

Latest DXCM News

View

Advertisement|Remove ads.

Advertisement|Remove ads.